Last edition
News about "Swapnil Shah"
Senores Pharmaceuticals Q1 FY27 Revenue Grows 35.9 Percent YoY to INR 180.2 Crore
Senores Pharmaceuticals reported 35.9 percent Year over Year (YoY) revenue growth to INR 180.2 crore in Q1 FY27, driven by regulated and emerging markets and higher profitability.
Swapnil Shah | 27/07/2026 | By News Bureau | 129
Senores Pharma Wins US FDA Approval for Deferiprone Tablets, Launched by Dr Reddy's
Senores Pharmaceuticals has announced the approval and US launch of Deferiprone Tablets USP (500 mg and 1000 mg), to be marketed by Dr Reddy’s Laboratories Inc.
Swapnil Shah | 15/12/2025 | By News Bureau | 283
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy